BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jia Y, Wen X, Gong Y, Wang X. Current scenario of indole derivatives with potential anti-drug-resistant cancer activity. Eur J Med Chem 2020;200:112359. [PMID: 32531682 DOI: 10.1016/j.ejmech.2020.112359] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 10.7] [Reference Citation Analysis]
Number Citing Articles
1 Yu C, E R, Zhang XW, Hu WQ, Bao G, Li Y, Liu Y, He Z, Li J, Ma W, Mou LY, Wang R, Sun W. NaClO-Mediated Cross Installation of Indoles and Azoles Benefits Anticancer Hit Discovery. ChemMedChem 2023;18:e202200651. [PMID: 36585386 DOI: 10.1002/cmdc.202200651] [Reference Citation Analysis]
2 Song J, Zhang B, Li M, Zhang J. The current scenario of naturally occurring indole alkaloids with anticancer potential. Fitoterapia 2023;165:105430. [PMID: 36634875 DOI: 10.1016/j.fitote.2023.105430] [Reference Citation Analysis]
3 Agrawal K, Patel T, Patel R. Synthesis, biological activity of newly designed sulfonamide based indole derivative as anti-microbial agent. Futur J Pharm Sci 2023;9:17. [DOI: 10.1186/s43094-023-00466-4] [Reference Citation Analysis]
4 Shagufta, Ahmad I. Therapeutic significance of molecular hybrids for breast cancer research and treatment. RSC Med Chem 2023;14:218-38. [PMID: 36846377 DOI: 10.1039/d2md00356b] [Reference Citation Analysis]
5 Fan CW, Li MS, Song XX, Luo L, Jiang JC, Luo JZ, Wang HS. Discovery of novel 2-oximino-2-indolylacetamide derivatives as potent anticancer agents capable of inducing cell autophagy and ferroptosis. Bioorg Med Chem 2023;80:117176. [PMID: 36709571 DOI: 10.1016/j.bmc.2023.117176] [Reference Citation Analysis]
6 Bender O, Celik I, Dogan R, Atalay A, Shoman ME, Ali TFS, Beshr EAM, Mohamed M, Alaaeldin E, Shawky AM, Awad EM, Ahmed AF, Younes KM, Ansari M, Anwar S. Vanillin-Based Indolin-2-one Derivative Bearing a Pyridyl Moiety as a Promising Anti-Breast Cancer Agent via Anti-Estrogenic Activity. ACS Omega 2023;8:6968-81. [PMID: 36844536 DOI: 10.1021/acsomega.2c07793] [Reference Citation Analysis]
7 Zhang H, Gao Y, Fu G, Liu J, Jiao Q. Trends and hotspots for European Journal of Medicinal Chemistry: A bibliometric study. Eur J Med Chem 2023;247:115041. [PMID: 36566715 DOI: 10.1016/j.ejmech.2022.115041] [Reference Citation Analysis]
8 Altıntop MD, Akalın Çiftçi G, Yılmaz Savaş N, Ertorun İ, Can B, Sever B, Temel HE, Alataş Ö, Özdemir A. Discovery of Small Molecule COX-1 and Akt Inhibitors as Anti-NSCLC Agents Endowed with Anti-Inflammatory Action. Int J Mol Sci 2023;24. [PMID: 36768971 DOI: 10.3390/ijms24032648] [Reference Citation Analysis]
9 Peng X, Rahim A, Peng W, Jiang F, Gu Z, Wen S. Recent Progress in Cyclic Aryliodonium Chemistry: Syntheses and Applications. Chem Rev 2023;123:1364-416. [PMID: 36649301 DOI: 10.1021/acs.chemrev.2c00591] [Reference Citation Analysis]
10 Petrou A, Geronikaki A, Kartsev V, Kousaxidis A, Papadimitriou-Tsantarliotou A, Kostic M, Ivanov M, Sokovic M, Nicolaou I, Vizirianakis IS. N-Derivatives of (Z)-Methyl 3-(4-Oxo-2-thioxothiazolidin-5-ylidene)methyl)-1H-indole-2-carboxylates as Antimicrobial Agents-In Silico and In Vitro Evaluation. Pharmaceuticals (Basel) 2023;16. [PMID: 36678628 DOI: 10.3390/ph16010131] [Reference Citation Analysis]
11 Zhang Y, Xu C, Xu X, Ma L, Li R, Xu Z, Zhao Q. Pharmacokinetics, tissue distribution, and antitumor activity of a novel compound, NY-2, in non-small cell lung cancer. Front Pharmacol 2022;13:1074576. [PMID: 36726788 DOI: 10.3389/fphar.2022.1074576] [Reference Citation Analysis]
12 Mari G, De Crescentini L, Favi G, Santeusanio S, Mantellini F. Straightforward Access to Pyrazine‐(2,3)‐diones through Sequential Three‐Component Reaction. Eur J Org Chem 2023. [DOI: 10.1002/ejoc.202201080] [Reference Citation Analysis]
13 Suliphuldevara Mathada B, Gunavanthrao Yernale N, Basha JN. The Multi‐Pharmacological Targeted Role of Indole and its Derivatives: A review. ChemistrySelect 2023;8. [DOI: 10.1002/slct.202204181] [Reference Citation Analysis]
14 Hu C, Zheng Y, Lin A, Zhang X, Wu X, Lin J, Xu X, Xiong Z. Design, synthesis and evaluation of indole-based bisacylhydrazone derivatives as α-glucosidase inhibitors. Journal of Molecular Structure 2023;1271:134124. [DOI: 10.1016/j.molstruc.2022.134124] [Reference Citation Analysis]
15 Zhao J, Carbone J, Farruggia G, Janecka A, Gentilucci L, Calonghi N. Synthesis and Antiproliferative Activity against Cancer Cells of Indole-Aryl-Amide Derivatives. Molecules 2022;28. [PMID: 36615458 DOI: 10.3390/molecules28010265] [Reference Citation Analysis]
16 Aleksanyan DV, Spiridonov AA, Churusova SG, Yu. Rybalkina E, Danshina AA, Peregudov AS, Klemenkova ZS, Kozlov VA. Thiophosphorylated indoles as a promising platform for the creation of cytotoxic Pd(II) pincer complexes. Inorganica Chimica Acta 2022. [DOI: 10.1016/j.ica.2022.121369] [Reference Citation Analysis]
17 Rzepka Z, Bębenek E, Chrobak E, Wrześniok D. Synthesis and Anticancer Activity of Indole-Functionalized Derivatives of Betulin. Pharmaceutics 2022;14:2372. [DOI: 10.3390/pharmaceutics14112372] [Reference Citation Analysis]
18 Bębenek E, Chrobak E, Rzepka Z, Wrześniok D. New Betulin Derivatives with Nitrogen Heterocyclic Moiety-Synthesis and Anticancer Activity In Vitro. Biomolecules 2022;12:1540. [PMID: 36291749 DOI: 10.3390/biom12101540] [Reference Citation Analysis]
19 Sflakidou E, Leonidis G, Foroglou E, Siokatas C, Sarli V. Recent Advances in Natural Product-Based Hybrids as Anti-Cancer Agents. Molecules 2022;27:6632. [PMID: 36235168 DOI: 10.3390/molecules27196632] [Reference Citation Analysis]
20 Rahman A, N P, N NB, Kumaraswamy HM, Rajeshwara AN, Satyanarayan ND. Synthesis and anticancer screening of some novel Pd-catalysed 3-methyl indole based analogues on Mia PaCa-2 cell line. Journal of Molecular Structure 2022;1264:133211. [DOI: 10.1016/j.molstruc.2022.133211] [Reference Citation Analysis]
21 Wu X, Zhang Y, Liu S, Liu C, Tang G, Cao X, Lei X, Peng J. Research applications of “linkers” in small molecule drugs design in fragment-based. Bioorganic Chemistry 2022. [DOI: 10.1016/j.bioorg.2022.105921] [Reference Citation Analysis]
22 Bansod PS, Jadhav SB. Design, Molecular Docking Studies and ADMET Prediction of Chalcones of Indole-Benzenesulfonyl Derivatives as Thioredoxin Inhibitor for Anticancer Activity. J Comput Biophys Chem 2022;21:361-371. [DOI: 10.1142/s2737416522500144] [Reference Citation Analysis]
23 Feng LS, Su WQ, Cheng JB, Xiao T, Li HZ, Chen DA, Zhang ZL. Benzimidazole hybrids as anticancer drugs: An updated review on anticancer properties, structure-activity relationship, and mechanisms of action (2019-2021). Arch Pharm (Weinheim) 2022;:e2200051. [PMID: 35385159 DOI: 10.1002/ardp.202200051] [Reference Citation Analysis]
24 Das A, Greco G, Kumar S, Catanzaro E, Morigi R, Locatelli A, Schols D, Alici H, Tahtaci H, Ravindran F, Fimognari C, Karki SS. Synthesis, in vitro cytotoxicity, molecular docking and ADME study of some indolin-2-one linked 1,2,3-triazole derivatives. Computational Biology and Chemistry 2022;97:107641. [DOI: 10.1016/j.compbiolchem.2022.107641] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Zhang H, Qi HZ, Mao J, Zhang HR, Luo QQ, Hu ML, Shen C, Ding L. Discovery of novel microtubule stabilizers targeting taxane binding site by applying molecular docking, molecular dynamics simulation, and anticancer activity testing. Bioorg Chem 2022;122:105722. [PMID: 35303622 DOI: 10.1016/j.bioorg.2022.105722] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
26 Wang Z, Ouyang G, Fan S, Fu Y, Tang S, Chen D, Li Z, Li C, Shao L. Design, Synthesis and Biological Evaluation of Novel Indole-Containing Sorafenib Derivatives. HETEROCYCLES 2022;104:667. [DOI: 10.3987/com-21-14586] [Reference Citation Analysis]
27 Hu Y, Chen S, Yang F, Dong S. Marine Indole Alkaloids-Isolation, Structure and Bioactivities. Mar Drugs 2021;19:658. [PMID: 34940657 DOI: 10.3390/md19120658] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
28 Wang G, Sun S, Guo H. Current status of carbazole hybrids as anticancer agents. Eur J Med Chem 2021;:113999. [PMID: 34838335 DOI: 10.1016/j.ejmech.2021.113999] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
29 Chen TL, Patel AS, Jain V, Kuppusamy R, Lin YW, Hou MH, Su TL, Lee TC. Discovery of Oral Anticancer 1,2-Bis(hydroxymethyl)benzo[g]pyrrolo[2,1-a]phthalazine Hybrids That Inhibit Angiogenesis and Induce DNA Cross-Links. J Med Chem 2021;64:12469-86. [PMID: 34459195 DOI: 10.1021/acs.jmedchem.0c01733] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Cardoso DSP, Szemerédi N, Spengler G, Mulhovo S, Dos Santos DJVA, Ferreira MU. Exploring the Monoterpene Indole Alkaloid Scaffold for Reversing P-Glycoprotein-Mediated Multidrug Resistance in Cancer. Pharmaceuticals (Basel) 2021;14:862. [PMID: 34577562 DOI: 10.3390/ph14090862] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
31 Tumosienė I, Jonuškienė I, Kantminienė K, Mickevičius V, Petrikaitė V. Novel N-Substituted Amino Acid Hydrazone-Isatin Derivatives: Synthesis, Antioxidant Activity, and Anticancer Activity in 2D and 3D Models In Vitro. Int J Mol Sci 2021;22:7799. [PMID: 34360565 DOI: 10.3390/ijms22157799] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
32 Zhang H, Mao J, Yang YL, Liu CT, Shen C, Zhang HR, Xie HZ, Ding L. Discovery of novel tubulin inhibitors targeting taxanes site by virtual screening, molecular dynamic simulation, and biological evaluation. J Cell Biochem 2021. [PMID: 34237164 DOI: 10.1002/jcb.30077] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
33 Teli G, Chawla PA. Hybridization of Imidazole with Various Heterocycles in Targeting Cancer: A Decade's Work. ChemistrySelect 2021;6:4803-36. [DOI: 10.1002/slct.202101038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
34 Li YS, Yang X, Zhao DS, Cai Y, Huang Z, Wu R, Wang SJ, Liu GJ, Wang J, Bao XZ, Ye XY, Wei B, Cui ZN, Wang H. Design, synthesis and bioactivity study on 5-phenylfuran derivatives as potent reversal agents against P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cell. Eur J Med Chem 2021;216:113336. [PMID: 33725657 DOI: 10.1016/j.ejmech.2021.113336] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
35 Chen T, Che C, Guo Z, Dong X, Wang C. Diastereoselective synthesis of functionalized tetrahydropyridazines containing indole scaffolds via an inverse-electron-demand aza-Diels–Alder reaction. Org Chem Front 2021;8:4392-8. [DOI: 10.1039/d1qo00623a] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
36 Wang Z, Lin X, Chen X, Li P, Li W. Organocatalytic stereoselective 1,6-addition of thiolacetic acids to alkynyl indole imine methides: access to axially chiral sulfur-containing tetrasubstituted allenes. Org Chem Front 2021;8:3469-74. [DOI: 10.1039/d1qo00394a] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
37 Liu W, Liang Y, Si X. Hydroxamic acid hybrids as the potential anticancer agents: An Overview. European Journal of Medicinal Chemistry 2020;205:112679. [DOI: 10.1016/j.ejmech.2020.112679] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
38 Meng T, Hou Y, Shang C, Zhang J, Zhang B. Recent advances in indole dimers and hybrids with antibacterial activity against methicillin-resistant Staphylococcus aureus. Arch Pharm (Weinheim) 2021;354:e2000266. [PMID: 32986279 DOI: 10.1002/ardp.202000266] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
39 Zhang Z, Jia C, Kong X, Hussain M, Liu Z, Liang W, Jiang L, Jiang H, Ma J. Sustainable Approach to Azaheterocyclic Acetamides by Decarboxylative Aminoformylation. ACS Sustainable Chem Eng 2020;8:16463-8. [DOI: 10.1021/acssuschemeng.0c05118] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
40 Xiao J, Gao M, Sun Z, Diao Q, Wang P, Gao F. Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010-2020). Eur J Med Chem 2020;208:112830. [PMID: 32992133 DOI: 10.1016/j.ejmech.2020.112830] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
41 Li J, Sun X, Li J, Yu F, Zhang Y, Huang X, Jiang F. The antimalarial activity of indole alkaloids and hybrids. Arch Pharm 2020;353:2000131. [DOI: 10.1002/ardp.202000131] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]